1 FTSE 100 stock to buy and hold!

Jabran Khan discusses the past and recent performance of this healthcase sector stalwart, as well as the current favourable market conditions.

| More on:
macro shot of computer monitor with FTSE 100 stock market data in trading application

Image source: Getty Images

FTSE 100 incumbent Smith & Nephew (LSE:SN) was impacted negatively by the pandemic. I believe it is primed to reap the benefits of reopening and should bounce back. Here’s why I’d add the shares to my holdings and keep hold of them.

Smith & Nephew shares drop

Smith & Nephew is a medical technology business that supports the healthcare sector to help return patients back to health and mobility. With a presence in over 100 countries, Smith & Nephew operates via three core segments. These are orthopaedics, sports medicine and ENT, and advanced wound management.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

So what’s the latest with Smith and Nephew shares? Well, as I write, the shares are trading for 1,300p. At this time last year, the shares were trading for 1,539p, which is a 15% decline over a 12-month period.

FTSE 100 stocks have risks

At current levels, Smith & Nephew shares could be deemed expensive. The shares currently trade on a price-to-earnings ratio of 27. The index average is closer to 15. If the business were to report less than pleasing results or reveal any negative news, the shares could be affected negatively.

Many of Smith & Nephew’s products are used in elective procedures. When the pandemic struck, fighting the virus was the primary concern of the healthcare sector. Many procedures were cancelled and Smith & Nephew’s performance was affected. There is a real risk of new variants and restrictions linked to the pandemic, in my opinion. This could once more affect the kinds of procedures that use Smith & Nephew’s products being put on the back burner.

The positives and my verdict

So what are the positives? Well, I’ll start with performance. Smith & Nephew has a good track record of consistent performance. I do understand that past performance is not a guarantee of the future, however. Looking back, I can see revenue has reached £4.9bn for the three of the past four years, aside from 2020, which was impacted by the pandemic, when it recorded revenue of £4.5bn. Again, aside from 2020, profit increased year on year between 2018 and 2021.

Coming up to date, Smith & Nephew reported a favourable Q1 trading update at the end of April. It said that revenue was up by 3.3% compared to the same period last year. In addition to this, all segments had seen growth and established and emerging markets had also seen growth compared to Q1 2021.

SN shares would also boost my passive income stream as the company has a good record of dividend payments. The current dividend yield stands at 2.5%. This is below the FTSE 100 average yield of 3%-4% but I’m buoyed by the consistent record of payouts from Smith & Nephew. It has paid a consistent dividend since 1937! There aren’t many businesses that can attest to such a feat.

Finally, due to the issues during the height of the pandemic, I believe Smith & Nephew will benefit from pent up demand for elective procedures and its products. This should help boost performance and any returns.

I’d add Smith & Nephew shares to my holdings, thanks to its fantastic dividend record and recent performance growth.

Inflation Is Coming: 3 Shares To Try And Hedge Against Rising Prices

Make no mistake… inflation is coming.

Some people are running scared, but there’s one thing we believe we should avoid doing at all costs when inflation hits… and that’s doing nothing.

Money that just sits in the bank can often lose value each and every year. But to savvy savers and investors, where to consider putting their money is the million-dollar question.

That’s why we’ve put together a brand-new special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation…

…because no matter what the economy is doing, a savvy investor will want their money working for them, inflation or not!

Best of all, we’re giving this report away completely FREE today!

Simply click here, enter your email address, and we’ll send it to you right away.

Jabran Khan has no position in any shares mentioned. The Motley Fool UK has recommended Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Saucepan on a gas hob
Investing Articles

The Centrica share price is up 65%. Here’s why I sold

The Centrica share price has soared nearly two-thirds in a year. So why has our writer dumped his shareholding?

Read more »

Modern suburban family houses with car on driveway
Investing Articles

As the Howden Joinery share price falls, I’d buy and hold

The Howden Joinery share price has been falling. But Christopher Ruane likes its business model and is weighing adding it…

Read more »

Hand holding pound notes
Investing Articles

The tumbling Persimmon share price means an 11.3% yield! Should I buy?

A falling Persimmon share price has pushed the dividend yield into double-digits. Our writer considers his next move.

Read more »

Innovation and new ideas lightbulb concept 2022
Investing Articles

As stock markets crash, I’d buy these 4 FTSE 100 fallers!

After US stock markets tumbled on Wednesday, the FTSE 100 duly followed suit on Thursday. But falling share prices revealed…

Read more »

Compass pointing towards 'best price'
Investing Articles

A 7.6% dividend yield! Is the Aviva share price a bargain not to be missed?

The Aviva share price has recovered well since the 2020 stock market crash. As one of the top FTSE 100…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

Stock market crash: I’m hunting giants for future gains!

In this latest stock market crash, selling pressure is slamming share prices. But some great company stocks are being crushed,…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

With a P/E of just 8, this social media newcomer is a cheap stock pick!

This social media firm looks like a cheap stock pick for my portfolio. For a growing tech firm, it certainly…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Warren Buffett has been selling dividend stocks. Should I be doing the same?

As Warren Buffett sells out of Abbvie, Bristol-Myers Squibb, and Verizon, our writer wonders whether he ought to be looking…

Read more »